| Title |
Antipsychotic medication for early episode schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2011
|
| DOI | 10.1002/14651858.cd006374.pub2 |
| Pubmed ID | |
| Authors |
John R Bola, Dennis Kao, Haluk Soydan, Clive E Adams |
| Abstract |
Long-term treatment with antipsychotic medications in early episode schizophrenia spectrum disorders is common, but both short and long-term effects on the illness are unclear. There have been numerous suggestions that people with early episodes of schizophrenia appear to respond differently than those with multiple prior episodes. The number of episodes may moderate response to drug treatment. |
X Demographics
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 17% |
| United States | 2 | 11% |
| Japan | 2 | 11% |
| Germany | 1 | 6% |
| France | 1 | 6% |
| India | 1 | 6% |
| Switzerland | 1 | 6% |
| Unknown | 7 | 39% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 67% |
| Practitioners (doctors, other healthcare professionals) | 4 | 22% |
| Scientists | 2 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 144 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| South Africa | 1 | <1% |
| Unknown | 142 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 23 | 16% |
| Student > Bachelor | 17 | 12% |
| Student > Ph. D. Student | 12 | 8% |
| Researcher | 11 | 8% |
| Student > Doctoral Student | 9 | 6% |
| Other | 31 | 22% |
| Unknown | 41 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 38 | 26% |
| Psychology | 20 | 14% |
| Nursing and Health Professions | 15 | 10% |
| Social Sciences | 8 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 4% |
| Other | 14 | 10% |
| Unknown | 43 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2024.
All research outputs
#1,513,172
of 25,707,225 outputs
Outputs from Cochrane database of systematic reviews
#3,213
of 13,137 outputs
Outputs of similar age
#6,367
of 127,010 outputs
Outputs of similar age from Cochrane database of systematic reviews
#16
of 101 outputs
Altmetric has tracked 25,707,225 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,137 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 127,010 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.